Estimating prognosis in end-stage renal disease

Progress in Palliative Care

Volumn 17, Issue 4, 2009, Pages 165-169

  Wittenberg, Stephen M ^a   Cohen, Lewis M ^a  

^a BAYSTATE MEDICAL CENTER   (United States)

Author keywords

Dialysis; Palliative care; Prognosis; Renal failure

Indexed keywords

ALBUMIN; TROPONIN T;

AGE; ALBUMIN BLOOD LEVEL; CARDIOVASCULAR DISEASE; CAREGIVER; COMORBIDITY; CONGESTIVE HEART FAILURE; DAILY LIFE ACTIVITY; DIALYSIS; DOCTOR PATIENT RELATION; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK POPULATION; HUMAN; INTERPERSONAL COMMUNICATION; KIDNEY FAILURE; LIFE EXPECTANCY; MEDICAL STAFF; MORTALITY; PROGNOSIS; REVIEW; SEX DIFFERENCE; SURVIVAL RATE; VASCULAR ACCESS;

EID: 70350150670     PISSN: 09699260     EISSN: 1743291X     Source Type: Journal    
DOI: 10.1179/096992609X12455871937026     Document Type: Review

References (63)

1. Christakis NA, Iwashyna TJ. Attitude and self-reported practice regarding prognostication in a national sample of internists. Arch Intern Med 1998; 158: 2389-2395.
2. Michel DM,Moss AH. Communicating prognosis in the dialysis consent process: a patient-centered, guideline-supported approach. Adv Chronic Kidney Dis 2005; 12: 196-201.
3. Weiner S, National Kidney Foundation. End-of-life care discussions: A survey of dialysis patients and professionals. J Nephrol Social Work 2008; 28: 52-58.
4. Fine A, Fontaine B, Kraushar MM, Rich BR. Nephrologists should voluntarily divulge survival data to potential dialysis patients: a questionnaire study. Perit Dial Int 2005; 25: 269-273.
5. Holley JL, Finucane TE, Moss AH. Dialysis patients' attitudes about cardiopulmonary resuscitation and stopping dialysis. Am J Nephrol 1989; 9: 245-251.
6. Badzek L, Hines SC, Moss AH. Inadequate self-care knowledge among elderly hemodialysis patients: assessing its prevalence and potential causes. ANNA J 1998; 25: 293-300.
7. Renal Physicians Association and American Society of Nephrology. Shared Decision-Making in the Appropriate Initiation of and Withdrawal from Dialysis, Clinical Practice Guideline Number 2. Washington, DC: Renal Physicians Association. 2000.
8. Hudson M, Weisbord S, Arnold R. Fast Fact and Concept #191: Prognostication in patients receiving dialysis. .
9. Robert Wood Johnson Foundation. ESRD workgroup final report summary on end-of-life care: recommendations to the field.Nephrol Nurs J 2003; 30: 59-63.
10. Ward AW. Telling the patient. J R Coll Gen Pract 1974; 24: 465-468.
11. Goldstein NE, Concato J, Bradley EH, O'Leary JR, Fried TR. Doctor-patient communication about prognosis: the influence of race and financial status. J Palliat Med 2005; 8: 998-1004.
12. Davison SN, Simpson C. Hope and advance care planning in patients with end stage renal disease: qualitative interview study. BMJ 2006; 333: 886-890.
13. Parascandola M, Hawkins J, Danis M. Patient autonomy and the challenge of clinical uncertainty. Kennedy Inst Ethics J 2002; 12: 245-264.
14. Holley JL, Carmody SS, Moss AH et al. The need for end-of-life care training in nephrology: national survey results of nephrology fellows. Am J Kidney Dis 2003; 42: 813-820.
15. Buckman R, Kayson Y. How to break bad news: a guide for health care professionals. Baltimore,MD: Johns Hopkins University Press, 1992.
16. Alpert JS, Wittenberg SW. A Clinicians Companion: A Study Guide for Effective and Humane Patient Care. Boston, MA: Little Brown, 1986; 169-172.
17. Price C. Nephrology community initiatives to develop guidelines for endof-life care. ANNA J 1998; 25: 573-578.
18. Moss AH, Holley JL, Davison SN et al. Palliative care. Am J Kidney Dis 2004; 43: 172-173.
19. Davison S, Jhangri G, Holley J, Moss A. Nephrologists' reported preparedness for end-of-life decision-making. Clin J Am Soc Nephrol 2006; 1: 1256-1262.
20. Calvin AO. Haemodialysis patients and end-of-life decisions: a theory of personal preservation. J Adv Nurs 2004; 46: 558-566.
21. Cohen LM,Moss AH,Weisbord SD,Germain MJ. Renal palliative care. J Palliat Med 2006; 9: 977-992.
22. Hebert PC. Truth-telling in clinical practice. Can Fam Phys 1994; 40: 2105-2113.
23. Weissman DE. Decision making at a time of crisis near the end of life. JAMA 2004; 292: 1738-1743.
24. Miyaji NT. Informed consent, cancer and truth in prognosis. N Engl J Med 1994; 331: 810.
25. Holcombe RF. Informed consent, cancer and truth in prognosis.NEngl J Med 1994; 331: 811.
26. Wright AA, Ray A, Zhang B et al. Medical care and emotional distress associated with advanced cancer patients' end-of-life discussions with their physicians. J Clin Oncol 2008; 26 (Suppl): 338s.
27. Weeks JC, Cook EF, O'Day SJ et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 1998; 279: 1709-1714.
28. Apatira L, Boyd EA, Malvar G et al. Hope, truth, and preparing for death: perspectives of surrogate decision makers. Ann Intern Med 2008; 149: 861-868.
29. Wyatt JC, Altman DG. Prognostic models: clinically useful or quickly forgotten? BMJ 1995; 311: 1539-1541.
30. Glare PA, Sinclair CT. Palliative medicine review: prognostication. J Palliat Med 2008; 11: 84-103.
31. Della Penna R.Asking the right question. J Palliat Med 2001; 4: 245-248.
32. Lynn J, Schuster JL, Kabcenell A. Improving care for the end of life: A sourcebook for health care managers and clinicians. New York: Oxford University Press, 2000; 5, 123, 144, 171.
33. Pattison M,Romer AL. Improving care through the end of life: launching a primary care clinic-based program. J Palliat Med 2001; 4: 249-254.
34. Moss AH, Ganjoo J, Sharma S et al. Utility of the 'surprise' question to identify dialysis patientswith highmortality.Clin J Am Soc Nephrol 2008; 3: 1379-1384.
35. Kutner NG, Brogan D, Fielding B. Physical and psychosocial resource variables related to long-term survival in older dialysis patients. Geriatr Nephrol Urol 1997; 7: 23-28.
36. Thong MS, Kaptein AA, Benyamini Y et al. Association between a self related health question andmortality in young and old dialysis patients: a cohort study. Am J Kidney Dis 2008; 52: 111-117.
37. van Dijk S, Sharloo M, Kaptein AA et al. Patients' representations of their end-stage renal disease: Relation with mortality. Nephrol Dial Transplant 2009;NDTAdvance Access, doi:10.1093/ndt/gfp184.
38. Miskulin DC,Martin AA, Brown R et al. Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments.Nephrol Dial Transplant 2004; 19: 413-420.
39. Mauri JM, Cleries M, Vela E, Catalan Renal Registry. Design and validation of amodel to predict earlymortality in haemodialysis patients. Nephrol Dial Transplant 2008; 23: 1690-1696.
40. Blake PG, Flowerdew G, Blake RM, Oreopoulos DG. Serumalbumin in patients on continuous ambulatory peritoneal dialysis-predictors and correlations with outcomes. J Am Soc Nephrol 1993; 3: 1501-1507.
41. Fried L, Bernardini J, Piraino B. Charlson Comorbidity Index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis 2001; 37: 337-342.
42. Fried L, Bernardini J, Piraino B. Comparison of the Charlson Comorbidity Index and the Davies score as a predictor of outcomes in PDpatients. Perit Dial Int 2003; 23: 568-573.
43. Beddhu S,Bruns FJ, Saul M, Seddon P,Zeidel ML.Asimple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 2000; 108: 609-613.
44. Hemmelgarn BR,Manns BJ,Quan H,Ghali WA.Adapting the Charlson Comorbidity Index for use in patientswith ESRD.Am J Kidney Dis 2003; 42: 125-132.
45. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
46. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001; 154: 854-864.
47. Tang J, Wan JY, Bailey JE. Performance of comorbidity measures to predict stroke and death in a community-dwelling, hypertensive Medicaid population. Stroke 2008; 39:1938-1944.
48. Mauri JM, Cleries M, Vela E, Catalan Renal Registry. Design and validation of amodel to predict earlymortality in haemodialysis patients. Nephrol Dial Transplant 2008; 23: 1690-1696.
49. Barrett BJ, Parfrey PS, Morgan J et al. Prediction of early death in endstage renal disease patients starting dialysis. Am J Kidney Dis 1997; 29: 214-222.
50. Couchoud C, Labeeuw M,Moranne O,et al. A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease.Nephrol Dial Transplant 2009; 24: 1553-1561.
51. Royal College of General Practitioners, National Gold Standards Framework Centre. Prognostic Indicator Guidance Paper. 2008 .
52. Johnston N, Dargie H, Jardine A. Diagnosis and treatment of coronary artery disease in patients with chronic kidney disease. Heart 2008; 94: 1080-1088.
53. McCullough PA,Li S, Stevens L, et al.Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. Am Heart J 2008; 156: 277-283.
54. Postorino M, Marino C, Tripepi G, Zoccali C. Prognostic value of the New York Heart Association classification in end-stage renal disease. Nephrol Dial Transplant 2007: 22: 1377-1382.
55. Paoletti E, Specchia C,Di Maio G, et al. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. Nephrol Dial Transplant 2004; 19: 1829-1834.
56. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45 (Suppl 3): S1-S153.
57. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998; 339: 799-805.
58. Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarction and renal dysfunction: a high risk combination. Ann Intern Med 2002; 137: 563-570.
59. Stack AG, Bloembergen WE. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis 2001; 38: 992-1000.
60. Banerjee D, Ma JZ, Collins AJ, Herzog CA. Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload.Clin J Am Soc Nephrol 2007; 2: 1186-1190.
61. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002; 106: 2941-2945.
62. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease; ameta-analysis.Circulation 2005; 112: 3088-3096.
63. Kanwar M,Hashem M,Rosman H, et al.Usefulness of clinical evaluation, troponins and C-reactive protein in predictingmortality among stable hemodialysis patients. Am J Cardiol 2006; 98: 1283-1287.